Exact Mass: 808.2062

Exact Mass Matches: 808.2062

Found 16 metabolites which its exact mass value is equals to given mass value 808.2062, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5,7-dihydroxyphthalide 6-O-beta-{6-O-{3'-methoxy-4'-O-beta-[6'-O-(4'-O-carboxy-3',5'-dimethoxy)phenyl]glucopyranosyl}phenyl}glucopyranoside|rhamnakoside A

5,7-dihydroxyphthalide 6-O-beta-{6-O-{3"-methoxy-4"-O-beta-[6"-O-(4""-O-carboxy-3"",5""-dimethoxy)phenyl]glucopyranosyl}phenyl}glucopyranoside|rhamnakoside A

C36H40O21 (808.2062)

tetrasodium,2-[[5-[1-[3-[[bis(carboxylatomethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-3-oxo-2-benzofuran-1-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(carboxylatomethyl)amino]acetate

tetrasodium,2-[[5-[1-[3-[[bis(carboxylatomethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-3-oxo-2-benzofuran-1-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(carboxylatomethyl)amino]acetate

C38H40N2Na4O12 (808.2172)

11-(Perfluorooctyl)undecyl dimorpholinophosphinate

C27H38F17N2O4P (808.2298)

Sodium 3-(3-carboxypropyl)-2-[3-(9-ethyl-6,8,8-trimethyl-2-phenyl-8,9-dihydropyrano[3,2-g]quinolin-1-ium-4-yl)prop-2-en-1-ylidene]-3-methyl-1-(3-sulfonatopropyl)indoline-5-sulfonate

C42H45N2NaO9S2 (808.2464)

D004396 - Coloring Agents > D002232 - Carbocyanines

Adenosine 5-diphosphoric acid beta-[1-[6-oxo-9-(2-deoxy-beta-D-ribofuranosyl)-1,6-dihydro-9H-purine-2-ylamino]-1,5-dideoxy-D-ribofuranose-5-yl] ester

C25H34N10O17P2 (808.1579)

Foxy-5 (TFA)

C28H43F3N6O14S2 (808.2231)

Foxy-5 TFA, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 TFA triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 TFA effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1][2][3].

(1s,3r,4r,5r)-3,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-bis({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy})cyclohexane-1-carboxylic acid

C43H36O16 (808.2003)

2-amino-8-[8-hydroxy-4-(hydroxymethyl)-9-(1h-indol-3-yl)-5-methyl-4,7-bis(methylsulfanyl)-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-16-yl]-3-oxophenoxazine-1,9-dicarboxylic acid

2-amino-8-[8-hydroxy-4-(hydroxymethyl)-9-(1h-indol-3-yl)-5-methyl-4,7-bis(methylsulfanyl)-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-16-yl]-3-oxophenoxazine-1,9-dicarboxylic acid

C39H32N6O10S2 (808.1621)

3,4-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,2-bis({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy})cyclohexane-1-carboxylic acid

C43H36O16 (808.2003)

2-amino-8-[(1r,4s,7s,8s,9r)-8-hydroxy-4-(hydroxymethyl)-9-(1h-indol-3-yl)-5-methyl-4,7-bis(methylsulfanyl)-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-16-yl]-3-oxophenoxazine-1,9-dicarboxylic acid

2-amino-8-[(1r,4s,7s,8s,9r)-8-hydroxy-4-(hydroxymethyl)-9-(1h-indol-3-yl)-5-methyl-4,7-bis(methylsulfanyl)-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-16-yl]-3-oxophenoxazine-1,9-dicarboxylic acid

C39H32N6O10S2 (808.1621)

(6-{8,16-dihydroxy-7,15-dimethoxy-3,11-dioxo-14-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,10-dioxatricyclo[10.4.0.0⁴,⁹]hexadeca-1(16),4,6,8,12,14-hexaen-6-yl}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoate

(6-{8,16-dihydroxy-7,15-dimethoxy-3,11-dioxo-14-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,10-dioxatricyclo[10.4.0.0⁴,⁹]hexadeca-1(16),4,6,8,12,14-hexaen-6-yl}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoate

C35H36O22 (808.1698)

[(2r,3s,4r,5r,6s)-6-{8,16-dihydroxy-7,15-dimethoxy-3,11-dioxo-14-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,10-dioxatricyclo[10.4.0.0⁴,⁹]hexadeca-1(16),4,6,8,12,14-hexaen-6-yl}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4r,5r,6s)-6-{8,16-dihydroxy-7,15-dimethoxy-3,11-dioxo-14-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,10-dioxatricyclo[10.4.0.0⁴,⁹]hexadeca-1(16),4,6,8,12,14-hexaen-6-yl}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C35H36O22 (808.1698)

(1r,2s,3s,4r)-3,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,2-bis({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy})cyclohexane-1-carboxylic acid

C43H36O16 (808.2003)